2 news items
Radius Announces Presentation of Data on TYMLOS (abaloparatide) at the World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases
RDUS
16 Apr 24
not been observed in observational studies in humans. There are limited data assessing the risk of osteosarcoma beyond 2 years of TYMLOS use. Avoid use
Radius Recycling Named One of the 2024 World's Most Ethical Companies
RDUS
4 Mar 24
The World's Most Ethical Companies® assessment is grounded in Ethisphere's proprietary Ethics
- Prev
- 1
- Next